[Rhabdomyolysis under treatment by ciprofibrate in the nephrotic syndrome].
D000328:Adult; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D058607:Fibric Acids; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D009404:Nephrotic Syndrome / Q000150:complications*; D012206:Rhabdomyolysis / Q000139:chemically induced*
D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C019304:ciprofibrate; D002994:Clofibrate
Rhabdomyolyse sous traitement par le ciprofibrate au cours d'un syndrome néphrotique.